Recall Register

Accriva Diagnostics, Inc.: FDA recalls

Newest recall start date in this list: . directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2

FDA enforcement events from 2022 to 2026; export dated . The recall start date and FDA report date are separate fields. Read the recall classes.

FDA enforcement reports name Accriva Diagnostics, Inc. as the recalling firm in 6 events. The events have 6 product records. The recalls started from 2022 to 2026. All the events are device recalls. By FDA enforcement events, Accriva Diagnostics, Inc. is number 591 of 1,629 firms that have a page. Events that Accriva Diagnostics, Inc. started: 2 in 2024 and 2 in 2025. For all FDA enforcement events, the count rose by 3.6%, from 1,773 in 2024 to 1,836 in 2025. Class II is 83.3% of its events and 73.7% of all FDA events.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Enforcement events

6 events, newest first.

FDA enforcement events of Accriva Diagnostics, Inc.
InitiatedProduct (first record)TypeClassRecordsStatus
30 Apr 2026directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2DeviceClass II1Ongoing
5 Nov 2025Hemochron Activated Clotting Time Low-Range Test Cuvette, REF: ACT-LR, to be used with the Hemochron Signature ELITE Whole Blood Microcoagulation SystemDeviceClass II1Ongoing
21 Oct 2025VerifyNow PRUTest Platelet Reactivity Test REF 85225 UDI-DI code: 10711234150078 The VerifyNow PRUTest is a whole blood test used in the laboratory or point of care setting to measure the level of platelet P2Y12 receptor blockade.DeviceClass III1Ongoing
2 Dec 2024VerifyNow P2Y12 Platelet Reactivity Test, REF: 85064DeviceClass II1Ongoing
27 Sep 2024AVOXimeter 1000E, Product Number: AVOX1000E. The AVOXimeter 1000E is a battery-operated bedside whole blood oximeter.DeviceClass II1Completed
30 Mar 2022The VerifyNow P2Y12 Test is designed to measure platelet P2Y12 receptor blockade. Substances known to specifically block the P2Y12 receptor include ticagrelor and the thienopyridine class of drugs, including clopidogrel and prasugrel.1-8 The test is based upon the ability of activated platelets to bind fibrinogen.…DeviceClass II1Terminated

An event with 1 product record and a class that is not Class I has no page. It has a row in this table.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Recalling firm: The firm that the FDA record names for a recall.

Type and class

Accriva Diagnostics, Inc.: events for each product type
TypeEvents
Device6
Accriva Diagnostics, Inc.: events in each class
ClassEvents
Class II5
Class III1
Share of the events of the firm in Class I
0%
Share of all events on the register in Class I
18%
Events with the status Ongoing
4

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Events by year

FDA enforcement events of Accriva Diagnostics, Inc., by the year that the recall started. The largest year is 2024, with 2 events.

Official channels

Cite this page

Recall Register. Accriva Diagnostics, Inc.: FDA recalls. https://recallregister.com/firm/accriva-diagnostics-inc/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
State of the firm address
CA

The firm name is the spelling in the FDA records. A company with 2 spellings has 2 pages.

A firm with more products can have more recalls. This site does not rate one firm against another. How the register is made. Report an error.

Questions

Which classes do the FDA recalls of Accriva Diagnostics, Inc. have?
Class II: 5 events. Class III: 1 event. The class is for the product of a recall. It is not a class of the firm.
What is the newest FDA recall of Accriva Diagnostics, Inc.?
FDA event 98979, which the firm started on 30 Apr 2026. The first product in the record is: directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2
How many FDA recalls of Accriva Diagnostics, Inc. have the status Ongoing?
4 events have the status Ongoing in the openFDA file. openFDA says about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.